SS Innovations International, Inc. Commences Trading on OTC under symbol SSII; Provides Corporate Update

SS Innovations International, Inc. (OTC: SSII), a developer of innovative, affordable and accessible surgical robotic technologies, has issued a corporate update.

The company, previously AVRA Medical Robotics, Inc., has completed a merger, changing its corporate name to SS Innovations International, Inc., and commencing trading on OTC with the new symbol SSII on May 12, 2023.

Highlights

SSII’s medical and engineering teams have developed a product range that includes its proprietary SSI Mantra surgical robotic system, and SSI Mudra, its wide range of surgical instruments.

The company has trained more than 50 robotic surgeons and completed over 180 surgeries across multiple specialties on its SSI Mantra Surgical Robotic System.

SSII has secured medical device regulatory and commercialization approvals for its devices in India, and intends to pursue FDA and CE approval processes in 2023.

SSII has a rapidly growing pipeline of system orders, initially in India.

 About SS Innovations International

SS Innovations International, Inc. (OTC: SSII) is a developer of innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger part of the global population. SSII’s product range includes its proprietary “SSI Mantra” surgical robotic system, and “SSI Mudra” is its wide range of surgical instruments capable of supporting a variety of surgical procedures including robotic cardiac surgery. SSII’s business operations are headquartered in India and the company has plans to expand the presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions, globally.

Disclaimer

This communication was produced by Prism MarketView, an affiliate of PCG Advisory Inc., (together “PCG”). PCG is an integrated investor relations, communications and strategic advisory firm. The information contained on this is ‘Paid Advertising’ for purposes of Section 17(b) of the Securities Act of 1933, as amended (together with the rules and regulations there under, the “Securities Act”). “PCG” and its affiliates are compensated by respective clients for publicizing information relating to its client’s securities. For more information in terms of compensation received for services provided by PCG, see the pertinent advertising materials relating to the respective client. By accessing this Site and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy…

Read Full Disclaimer

Share This Article

 

About the Author

SS Innovations International, Inc. Commences Trading on OTC under symbol SSII; Provides Corporate Update

Editor Prism MarketView